MedPath

P-study

Completed
Conditions
healthy volunteers
Registration Number
NL-OMON25579
Lead Sponsor
utricia Research
Brief Summary

o

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

Age ≥ 18 and ≤ 40 years

- Non-Asian race*

Exclusion Criteria

- Any medical condition that interferes significantly with digestion and/or gastrointestinal (GI) function (e.g. inflammatory bowel disease, gastroesophageal reflux disease, diaphraghma hernia or diaphraghma surgery, gastric ulcer, gastritis, (gastro)enteritis, gall bladder problems, pancreatitis, GI cancer, oesophageal and/or gastric surgery)

- Known renal or hepatic failure or known thyroid dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome parameter in this study is the serum P AUC(0-360) [mmol/L*min] (product A compared to product B).
Secondary Outcome Measures
NameTimeMethod
The secondary outcome parameters in this study are comparisons of product A and B on:<br /><br>- Serum P [mmol/L] (product A - B), Cmax, iCmax [mmol/L], Tmax [min]<br /><br>- Serum Ca [mmol/L] (product A - B), Cmax, iCmax [mmol/L], AUC(0-360) [mmol/L*min], iAUC(0-360) [mmol/L*min], Tmax [min]<br /><br>- Serum creatinine [µmol/L] (product A - B), Cmax, AUC0-360 [µmol/L*min], Tmax [min]<br /><br>- Serum iPTH [pmol/L] (product A - B), Cmax, AUC0-360 [pmol/L*min], Tmax [min]<br /><br>- Serum AP [U/L] (product A - B), Cmax, AUC0-360 [U/L*min], Tmax [min] <br /><br><br /><br>- Urinary P [mmol/L] (product A - B), Cmax, iCmax [mmol/L], AUC(0-370) [mmol/L*min], iAUC0-370 [mmol/L*min] and Tmax [min]<br /><br>- Urinary Ca [mmol/L] (product A - B), Cmax, iCmax [mmol/L], AUC(0-370) [mmol/L*min], iAUC0-370 [mmol/L*min] and Tmax [min]<br /><br>- Urinary creatinine [mmol/L] (product A - B), Cmax, AUC(0-370) [mmol/L*min] and Tmax [min]<br>
© Copyright 2025. All Rights Reserved by MedPath